Functional, nonepileptic seizures linked to higher death rate than expected

The death rate for patients with functional, nonepileptic seizures is higher than expected, with a rate comparable to epilepsy and severe mental illness, a Michigan Medicine-led study finds.

A contrarian view on Viking Therapeutics, biotech’s hottest obesity stock

This is the inaugural edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday

March 28, 2024

Revive Therapeutics Provides Update From FDA Meeting for Long COVID Diagnostic Product | Psychedelic Invest

TORONTO, June 10, 2024 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused

June 11, 2024

Fresh from rebrand, Spyre Therapeutics raises $180M as it steers TLA1 program to clinic

Spyre Therapeutics is pulling in $180 million in a private placement just a couple of weeks after it rebranded from Aeglea BioTherapeutics. Spyre is selling

December 9, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.